News
MedPage Today on MSN1d
FDA Chief Defends Job Cuts, COVID Booster Policy at Senate HearingSeven weeks into his job as FDA commissioner, Marty Makary, MD, MPH, held his own answering a barrage of sometimes ...
Q: Did President Donald Trump call military nurse Ruby Bradley a “loser,” and were there orders for her service history to be removed from Department of Defense archives?
FDA chief pushes back on senators’ criticism, says Covid booster trials should take ‘roughly a year’
The hearing was supposed to focus on the Trump administration’s 2026 budget request, but instead covered a wide range of ...
The FDA will limit the vaccine’s availability later this year to older adults and those who may be at risk of severe illness.
On May 20, U.S. Food and Drug Administration (FDA) officials announced that Covid-19 vaccines will no longer be available to ...
Government advisers are meeting Thursday to decide if COVID-19 vaccines need updating to improve protection this fall and ...
The change marks a shift in the Food and Drug Administration’s policy on approving COVID-19 vaccines, which the new ...
The FDA’s recent activities regarding Covid-19 vaccines stray far from the well-established standards of vaccine regulatory ...
The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.
The FDA is tightening its regulatory policy around COVID vaccines with a new framework that raises the bar for certain ...
The new framework was well-received by biopharma analysts, who say it “largely formalizes” current COVID-19 vaccination ...
The restrictions on Novavax's vaccine could portend changes at the FDA. Commissioner Marty Makary suggested last week that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback